Gene redundancy and pharmacological gene therapy: Implications for X-linked adrenoleukodystrophy
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
As more functional redundancy in mammalian cells is discovered, enhanced expression of genes involved in alternative pathways may become an effective form of gene therapy. X-linked adrenoleukodystrophy (X-ALD) is a peroxisomal disorder with impaired very-long-chain fatty acid metabolism. The X-ALD gene encodes a peroxisomal membrane protein (ALDP) that is part of a small family of related peroxisomal membrane proteins. We show that 4-phenylbutyrate treatment of cells from both X-ALD patients and X-ALD knockout mice results in decreased levels of and increased beta-oxidation of very-long-chain fatty acids; increased expression of the peroxisomal protein ALDRP; and induction of peroxisome proliferation. We also demonstrate that ALDP and ALDRP are functionally related, by ALDRP cDNA complementation of X-ALD fibroblasts. Finally, we demonstrate the in vivo efficacy of dietary 4-phenylbutyrate treatment through its production of a substantial reduction of very-long-chain fatty acid levels in the brain and adrenal glands of X-ALD mice.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Dietary treatment with 4PBA in ALD 2 mice has been shown to partially correct the accumulation of VLCFAs in brain and adrenal glands, correlating with ALDR protein induction and increased peroxisome proliferation (27).”
From Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy (2004) · cites this paper as [27]
In the citing paper
“Consistently, the residual peroxisomal β-oxidation of VLCFA is ~20% of normal in X-ALD fibroblasts [150,151] and can be restored by ABCD2 or ABCD3 overexpression [152,153].”
From Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy (2025) · cites this paper as [153]
In the citing paper
“Overexpression of ALDRP cDNA in human and mouse X-ALD fibroblasts completely restores VLCFA β-oxidation and results in normal levels of VLCFAs [Kemp et al., 1998;Netik et al., 1999].”
From ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: Role in diagnosis and clinical correlations (2001) · cites this paper as Kemp et al., 1998
In the citing paper
“The expression of the ABCD2 gene can be induced pharmacologically both in vitro and in vivo with 4-phenylbutyrate and fenofibrate [Kemp et al., 1998;Netik et al., 1999].”
From ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: Role in diagnosis and clinical correlations (2001) · cites this paper as Kemp et al., 1998
In the citing paper
“increasing the expression of an alternate gene (ALDR, ABCD2), which can substitute, at least in part, for the function of ALDP (ABCD1) [Kemp et al., 1998]”
From ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: Role in diagnosis and clinical correlations (2001) · cites this paper as Kemp et al., 1998
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,786
Annals of the New York Academy of Sciences
(2019) · Annals of the New York Academy of Sciences · doi:10.1111/(issn)1749-6632 · Cited by 1,305
Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters
Mosser, J., Douar, A.-M., Sarde, C.-O., Kioschis, P., Feil, R., Moser, H., Poustka, A.-M., Mandel, J.-L., & Aubourg, P. (1993) · Nature · doi:10.1038/361726a0 · Cited by 1,202
The metabolic basis of inherited disease
Goldstein, J. L. (1995) · Medical Entomology and Zoology · Cited by 1,009
Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene
Tinsley, J. M., Potter, A. C., Phelps, S. R., Fisher, R., Trickett, J. I., & Davies, K. E. (1996) · Nature · doi:10.1038/384349a0 · Cited by 490
Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy
Moser, H. (1997) · Brain · doi:10.1093/brain/120.8.1485 · Cited by 478
A Short-Term Trial of Butyrate to Stimulate Fetal-Globin-Gene Expression in the β-Globin Disorders
Perrine, S. P., Ginder, G. D., Faller, D. V., Dover, G. H., Ikuta, T., Witkowska, H. E., Cai, S.-P., Vichinsky, E. P., & Olivieri, N. F. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301143280202 · Cited by 437
Kamijo, K., Taketani, S., Yokota, S., Osumi, T., & Hashimoto, T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39595-x · Cited by 391
Rubenstein, R. C., Egan, M. E., & Zeitlin, P. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119788 · Cited by 389
Research works printed but not linked: 1
- Moser, H.W. & Moser, A.B. in Techniques in Diagnostic Biochemical Genetics: A Laboratory Manual (ed. A., H.F.) 177– 191 (Wiley-Liss, New York, 1991).
Cited by
Items 101–200 of 248
Liver X Receptor α Interferes with SREBP1c-mediated Abcd2 Expression
Weinhofer, I., Kunze, M., Rampler, H., Bookout, A. L., Forss‐Petter, S., & Berger, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509450200 · Cited by 45
Oligodendrocyte lineage and the motor neuron connection
Richardson, W. D., Smith, H. K., Sun, T., Pringle, N. P., Hall, A., & Woodruff, R. (2000) · Glia · doi:10.1002/(sici)1098-1136(20000115)29:2<136::aid-glia6>3.0.co;2-g · Cited by 191
Metabolic rerouting via SCD1 induction impacts X-linked adrenoleukodystrophy
Raas, Q., van de Beek, M.-C., Forss‐Petter, S., Dijkstra, I. M. E., Deschiffart, A., Freshner, B. C., Stevenson, T. J., Jaspers, Y. R. J., Nagtzaam, L., Wanders, R. J. A., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142500 · Cited by 44
Self-citationThyroid Hormone Induction of the Adrenoleukodystrophy-Related Gene (ABCD2)
Fourcade, S., Savary, S., Gondcaille, C., Berger, J., Netik, A., Cadepond, F., El‐Etr, M., Molzer, B., & Bugaut, M. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.6.1296 · Cited by 45
Camacho, J. A., Rioseco‐Camacho, N., Andrade, D., Porter, J., & Kong, J. (2003) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(03)00105-7 · Cited by 40
Recent advances in the molecular genetics of congenital and acquired primary adrenocortical failure
Vaidya, B., Pearce, S. H. S., & Kendall‐Taylor, P. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01116.x · Cited by 40
Molecular genetics of peroxisomal disorders
Hugo, W. M. (2000) · Frontiers in bioscience · doi:10.2741/moser · Cited by 39
Pharmacologic restoration of αδF508 CFTR-mediated chloride current
Zeitlin, P. L. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00922.x · Cited by 42
Peroxisome deficient invertebrate and vertebrate animal models
Veldhoven, P. P. V., & Baes, M. I. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00335 · Cited by 44
Singh, J., Khan, M., & Singh, I. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m017491 · Cited by 37
Oezen, I., Rossmanith, W., Forss‐Petter, S., Kemp, S., Voigtländer, T., Moser-Thier, K., Wanders, R. J. A., Bittner, R. E., & Berger, J. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi125 · Cited by 42
Self-citationFuture Pharmacological Treatment of Cystic Fibrosis
Zeitlin, P. L. (2000) · Respiration · doi:10.1159/000029528 · Cited by 36
Epigenetics, fragile X syndrome and transcriptional therapy
Tabolacci, E., & Chiurazzi, P. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36264 · Cited by 40
Smith, B. T., Sengupta, T. K., & Singh, I. (2000) · Experimental Cell Research · doi:10.1006/excr.1999.4757 · Cited by 41
[56] Peroxisomal ABC transporters
Shani, N., & Valle, D. L. (1998) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(98)92058-4 · Cited by 38
X-linked adrenoleukodystrophy phenotype is independent of ABCD2 genotype
Maier, E. M., Mayerhofer, P. U., Asheuer, M., Köhler, W., Rothe, M., Muntau, A. C., Roscher, A. A., Holzinger, A., Aubourg, P., & Berger, J. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.09.092 · Cited by 34
Induction of the adrenoleukodystrophy-related gene (ABCD2) by thyromimetics
Genin, E. C., Gondcaille, C., Trompier, D., & Savary, S. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.04.006 · Cited by 37
Depreter, M., Vandesompele, J., Espeel, M., Speleman, F., & Roels, F. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1750779 · Cited by 38
Muneer, Z., Wiesinger, C., Voigtländer, T., Werner, H. B., Berger, J., & Forss-Petter, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108655 · Cited by 33
Manor, J., Chung, H., Bhagwat, P. K., & Wangler, M. F. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24953 · Cited by 32
Effect of dietary polyunsaturated fatty acids on the expression of peroxisomal ABC transporters
Leclercq, S., Skrzypski, J., Courvoisier, A., Gondcaille, C., Bonnetain, F., André, A., Chardigny, J., Bellenger, S., Bellenger, J., Narce, M., et al. (2008) · Biochimie · doi:10.1016/j.biochi.2008.05.022 · Cited by 37
Peroxisomal ROS control cytosolic Mycobacterium tuberculosis replication in human macrophages
Pellegrino, E., Aylan, B., Bussi, C., Fearns, A., Bernard, E. M., Athanasiadi, N., Santucci, P., Botella, L., & Gutierrez, M. G. (2023) · The Journal of Cell Biology · doi:10.1083/jcb.202303066 · Cited by 38
Mouse Very Long-chain Acyl-CoA Synthetase in X-linked Adrenoleukodystrophy
Heinzer, A. K., Kemp, S., Lu, J., Watkins, P. A., & Smith, K. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203053200 · Cited by 33
Self-citationTargeting foam cell formation in inflammatory brain diseases by the histone modifier MS‐275
Zierfuss, B., Weinhofer, I., Buda, A., Popitsch, N. P., Hess, L., Moos, V., Hametner, S., Kemp, S., Köhler, W., Forss‐Petter, S., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51200 · Cited by 31
Self-citationSingh, I., Singh, A. K., & Contreras, M. A. (2009) · Journal of Child Neurology · doi:10.1177/0883073809338327 · Cited by 32
Melhem, E. R., Barker, P. B., Raymond, G. V., & Moser, H. W. (1999) · American Journal of Roentgenology · doi:10.2214/ajr.173.6.10584804 · Cited by 34
Chung, Y. L., Lee, Y. W., Yen, S. H., & Chi, K. H. (2000) · PubMed · Cited by 32
Emerging chemotherapeutic strategies for Huntington’s disease
Ryu, H., & Ferrante, R. J. (2005) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.10.2.345 · Cited by 29
Yamada, T., Shinnoh, N., Taniwaki, T., Ohyagi, Y., Asahara, H., Horiuchi, I., & Kira, J. (2000) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005634130286 · Cited by 29
Hepatocyte Polarity and the Peroxisomal Compartment: A Comparative Study
Depreter, M., Walker, T. M., Smet, K. D., Beken, S., Kerckaert, I., Rogiers, V., & Roels, F. (2002) · The Histochemical Journal · doi:10.1023/a:1020990414190 · Cited by 28
Essadek, S., Gondcaille, C., Savary, S., Samadi, M. H., Vamecq, J., Lizard, G., Kebbaj, R. E., Latruffe, N., Bénani, A., Nasser, B., et al. (2023) · Antioxidants · doi:10.3390/antiox12010168 · Cited by 28
Weinhofer, I., Kunze, M., Rampler, H., Forss‐Petter, S., Samarut, J., Plateroti, M., & Berger, J. (2008) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2008.08.002 · Cited by 28
Evaluation of the therapeutic potential of PPARα agonists for X-linked adrenoleukodystrophy
Rampler, H., Weinhofer, I., Netik, A., Forss‐Petter, S., Brown, P. J., Oplinger, J. A., Bugaut, M., & Berger, J. (2003) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2003.09.002 · Cited by 29
Simvastatin does not normalize very long chain fatty acids in adrenoleukodystrophy mice
Cartier, N., Guidoux, S., Rocchiccioli, F., & Aubourg, P. R. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01852-4 · Cited by 28
Morita, M., Takahashi, I., Kanai, M., Okafuji, F., Iwashima, M., Hayashi, T., Watanabe, S., Hamazaki, T., Shimozawa, N., Suzuki, Y., et al. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.11.102 · Cited by 26
Yamada, T., Ohyagi, Y., Shinnoh, N., Kikuchi, H., Osoegawa, M., Ochi, H., Kira, J., & Furuya, H. (2003) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2003.11.006 · Cited by 25
Vorinostat in the acute neuroinflammatory form of X‐linked adrenoleukodystrophy
Zierfuss, B., Weinhofer, I., Kühl, J., Köhler, W., Bley, A. E., Zauner, K., Binder, J., Martinović, K., Seiser, C., Hertzberg, C., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51015 · Cited by 27
Self-citationSingh, J., Khan, M., Pujol, A., Baarine, M., & Singh, I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070712 · Cited by 24
Mouse Models and Genetic Modifiers in X-Linked Adrenoleukodystrophy
Heinzer, A. K., McGuinness, M. C., Lu, J., Stine, O. C., Wei, H., Vlies, M. V. D., Dong, G.-X., Powers, J. F., Watkins, P. A., & Smith, K. D. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9072-3_12 · Cited by 25
Self-citationPujol, A., Troffer-Charlier, N., Metzger, E., Chimini, G., & Mandel, J. (2000) · Genomics · doi:10.1006/geno.2000.6367 · Cited by 25
Singh, J., Olle, B., Suhail, H., Felicella, M. M., & Giri, S. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13562 · Cited by 25
Singh, J., Khan, M., & Singh, I. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.01.004 · Cited by 21
(2006) · Springer eBooks · doi:10.1007/3-540-29623-9_9160 · Cited by 21
Makkar, R. S., Contreras, M. A., Paintlia, A. S., Smith, B. T., Haq, E., & Singh, I. (2006) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2006.05.003 · Cited by 24
Therapeutic developments in peroxisome biogenesis disorders
McGuinness, M. C., Wei, H., & Smith, K. D. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.9.1985 · Cited by 21
Self-citationEngelen, M., Ofman, R., Mooijer, P. A. W., Poll‐The, B. T., Wanders, R. J. A., & Kemp, S. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.12.003 · Cited by 23
Self-citationRothberg, B. E. G., Sundseth, S. S., DiPippo, V. A., Brown, P. J., Winegar, D. A., Gottshalk, W. K., Shenoy, S. G., & Rothberg, J. M. (2001) · Functional & Integrative Genomics · doi:10.1007/s101420000022 · Cited by 21
G1 Phase Growth Arrest and Induction of p21 in IB3-1 Cells Treated with 4-Sodium Phenylbutyrate
McGrath‐Morrow, S. A., & Stahl, J. L. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39156-6 · Cited by 21
Inherited disorders of sarcomeric proteins
Laing, N. G. (1999) · Current Opinion in Neurology · doi:10.1097/00019052-199910000-00004 · Cited by 21
LXR antagonists induce ABCD2 expression
Gondcaille, C., Genin, E. C., Lopez, T. E., Dias, A. M. M., Geillon, F., Andreoletti, P., Cherkaoui‐Malki, M., Nury, T., Lizard, G., Weinhofer, I., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.11.003 · Cited by 23
Wichers, M., Köhler, W., Brennemann, W., Boese, V., Sokolowski, P., BIDLINGMAIER, F., & Ludwig, M. Z. (1999) · Human Genetics · doi:10.1007/s004390051072 · Cited by 23
Holzinger, A., Mayerhofer, P., Berger, J., Lichtner, P., Kammerer, S., & Roscher, A. A. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0535 · Cited by 23
The clinical course of childhood and adolescent adrenoleukodystrophy before and after Lorenzo's oil
Suzuki, Y., Imamura, A., Shimozawa, N., & Kondo, N. (2001) · Brain and Development · doi:10.1016/s0387-7604(00)00196-0 · Cited by 21
Braiterman, L. T., Watkins, P. A., Moser, A. B., & Smith, K. D. (1999) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1998.2789 · Cited by 20
Self-citationAlbet, S., Bentejac, M., Savary, S., Gondcaille, C., Netik, A., Berger, J., Szpirer, C., Troffer-Charlier, N., & Bugaut, M. (2001) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(00)00291-8 · Cited by 18
Regulation of the adrenoleukodystrophy-related gene (ABCD2): Focus on oxysterols and LXR antagonists
Trompier, D., Gondcaille, C., Lizard, G., & Savary, S. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.01.025 · Cited by 19
Differential roles for ACBD4 and ACBD5 in peroxisome-ER interactions and lipid metabolism.
Costello, J. L., Koster, J., Silva, B. S. C., Worthy, H. L., Schrader, T. A., Hacker, C., Passmore, J., Kuypers, F. A., Waterham, H. R., & Schrader, M. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105013 · Cited by 18
Turk, B. R., Theda, C., Fatemi, A. S., & Moser, A. B. (2019) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2019.11.002 · Cited by 19
Self-citationEvaluation of Therapy of X-Linked Adrenoleukodystrophy
Moser, H. W., Fatemi, A. S., Zackowski, K. M., Smith, S., Golay, X., Muenz, L. R., & Raymond, G. V. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000021245.12181.90 · Cited by 17
Wang, T., Xie, Y., Tan, A., Li, S., & Xie, Z. (2015) · ACS Synthetic Biology · doi:10.1021/acssynbio.5b00180 · Cited by 17
Moser, H. W., Bezman, L., Lu, S., & Raymond, G. V. (2000) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005688130338 · Cited by 17
Trompier, D., & Savary, S. (2013) · Colloquium Series on The Genetic Basis of Human Disease · doi:10.4199/c00075ed1v01y201303gbd004 · Cited by 18
Baicalein 5,6,7‐trimethyl ether activates peroxisomal but not mitochondrial fatty acid β‐oxidation
Morita, M., Kanai, M., Mizuno, S., Iwashima, M., Hayashi, T., Shimozawa, N., Suzuki, Y., & Imanaka, T. (2008) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-0857-2 · Cited by 15
Hematopoietic Cell Transplantation for Storage Diseases
Peters, C. (2003) · Wiley eBooks · doi:10.1002/9780470987070.ch107 · Cited by 15
Park, C., Kim, H.-S., Jang, J., Lee, H., Lee, J. S., Yoo, J., Lee, D. R., & Kim, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056242 · Cited by 16
Liu, M., Brusilow, W. S. A., & Needleman, R. B. (2004) · Current Genetics · doi:10.1007/s00294-004-0531-7 · Cited by 14
Diseases of intramembranous lipid transport
Paulusma, C. C., & Elferink, R. P. J. O. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.06.067 · Cited by 15
Reactivation of silenced genes and transcriptional therapy
Chiurazzi, P., & Neri, G. (2003) · Cytogenetic and Genome Research · doi:10.1159/000072838 · Cited by 16
Raymond, G. V. (1999) · Current Opinion in Pediatrics · doi:10.1097/00008480-199912000-00017 · Cited by 13
Gueugnon, F., Gondcaille, C., Leclercq, S., Bellenger, J., Bellenger, S., Narce, M., Pineau, T., Bonnetain, F., & Savary, S. (2007) · Biochimie · doi:10.1016/j.biochi.2007.06.013 · Cited by 14
Downregulation of ABCD1 in Human Renal Cell Carcinoma
Hour, T., Kuo, Y.-Z., Liu, G., Kang, W.-Y., Huang, C., Tsai, Y., Wu, W., Huang, S., & Pu, Y. (2009) · The International Journal of Biological Markers · doi:10.5301/jbm.2009.3280 · Cited by 12
On the Front of X-Linked Adrenoleukodystrophy
Aubourg, P. R. (1999) · Neurochemical Research · doi:10.1023/a:1022583813171 · Cited by 15
Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy
Bougnères, P., & Le Stunff, C. (2025) · Genes · doi:10.3390/genes16050590 · Cited by 11
Nemeth, C. L., Gök, Ö., Tomlinson, S. N., Sharma, A., Moser, A. B., Kannan, S., Kannan, R. M., & Fatemi, A. S. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01311-x · Cited by 12
Self-citationTreatment: Present Status and New Trends
Walter, J. H., & Wraith, J. E. (2006) · Springer eBooks · doi:10.1007/978-3-540-28785-8_5 · Cited by 11
Is There Treatment for “Genetic” Disease?
Scriver, C. R., & Treacy, E. P. (1999) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1999.2907 · Cited by 10
Biochemical effect of intravenous arginine butyrate in x-linked adrenoleukodystrophy
McGovern, M. M., Wasserstein, M., Aron, A. M., & Perrine, S. P. (2003) · The Journal of Pediatrics · doi:10.1067/mpd.2003.201 · Cited by 10
Disorders related to peroxisomal membranes
Gärtner, J. (2000) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005636113499 · Cited by 10
Identification of enzymes involved in oxidation of phenylbutyrate
Palir, N., Ruiter, J. P. N., Wanders, R. J. A., & Houtkooper, R. H. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m075317 · Cited by 9
(2005) · Springer eBooks · doi:10.1007/3-540-27660-2_21 · Cited by 9
A novel cell model to study the function of the adrenoleukodystrophy-related protein
Gueugnon, F., Volodina, N., Taouil, J. E., Lopez, T. E., Gondcaille, C., Grand, A. S.-L., Mooijer, P. A. W., Kemp, S., Wanders, R. J. A., & Savary, S. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.152 · Cited by 12
Self-citationCell division cycle control in embryonal and alveolar rhabdomyosarcomas
Moretti, A., Borriello, A., Monno, F., Criscuolo, M., Rosolen, A., Esposito, G., Iacovo, R. D., Ragione, F. D., & Iolascon, A. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00454-9 · Cited by 9
Weber, F. D., Weinhofer, I., Einwich, A., Forss-Petter, S., Muneer, Z., Maier, H., Weber, W. H. A., & Berger, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103742 · Cited by 8
Honsho, M., Hashiguchi, Y., Ghaedi, K., & Fujiki, Y. (2010) · The Journal of Biochemistry · doi:10.1093/jb/mvq130 · Cited by 8
Transporteurs ABC peroxysomaux et adrénoleucodystrophie liée au chromosome X
Geillon, F., Trompier, D., Gondcaille, C., Lizard, G., & Savary, S. (2012) · médecine/sciences · doi:10.1051/medsci/20122812019 · Cited by 10
Zinn, A. B. (2011) · Elsevier eBooks · doi:10.1016/b978-0-323-06545-0.00059-5 · Cited by 7
Monternier, P., Parasar, P., Theurey, P., Dagorn, P. G., Kaur, N., Nagaraja, T. N., Fouqueray, P., Bolze, S., Moller, D. E., Singh, J., et al. (2022) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001208 · Cited by 9
Psychosocial Care of the Child and Family
Harris, J. C. (2000) · Springer eBooks · doi:10.1007/978-3-662-04285-4_4 · Cited by 7
Moser, A. B., Liu, Y., Shi, X., Schrifl, U., Hiebler, S., Fatemi, A. S., Braverman, N., Steinberg, S. J., & Watkins, P. A. (2021) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30014 · Cited by 8
Self-citationPeroxisome Metabolism Contributes to PIEZO2-Mediated Mechanical Allodynia
Gong, Y., Laheji, F. K., Berenson, A., Qian, A., Park, S.-O., Kok, R., Selig, M. K., Hahn, R., Sadjadi, R., Kemp, S., et al. (2022) · Cells · doi:10.3390/cells11111842 · Cited by 7
Self-citationPharmacological Induction of Redundant Genes for a Therapy of X-ALD
Bugaut, M., Fourcade, S., Gondcaille, C., Gueugnon, F., Depreter, M., Roels, F., Netik, A., Berger, J., Martin, P. G. P., Pineau, T., et al. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9072-3_36 · Cited by 9
Netik, A., Höbel, A., Rauschka, H., Molzer, B., Forss‐Petter, S., & Berger, J. (2000) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005686114356 · Cited by 7
The mouse as a model to understand peroxisomal biogenesis and its disorders
Brites, P., Wanders, R. J. A., & Waterham, H. R. (2004) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2004.09.003 · Cited by 6
Principles of management of the more common metabolic disorders
Chakrapani, A., & Wraith, J. E. (2002) · Current Paediatrics · doi:10.1054/cupe.2001.0262 · Cited by 6
Peroxisomal Disorders in Children
Watkins, P. A., Chen, L., & Braverman, N. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108918978.037 · Cited by 5
Self-citationAlger, S., Green, A., Köhler, W., Sokolowski, P., & Moser, H. (2000) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005604012362 · Cited by 6
Moser, H. W. (2004) · Elsevier eBooks · doi:10.1016/b978-012439510-7/50087-5 · Cited by 7
Characterisation of the ovine model of McArdle's disease: development of therapeutic strategies
Walker, K. R. (2006) · Murdoch University Research Portal · Cited by 6
Wang, M., Chen, Y., Guo, M., Xie, P., Zhao, X., Chen, S., Deng, Y., Hu, R., Wan, Q., Zhou, J., et al. (2026) · Developmental Cell · doi:10.1016/j.devcel.2025.12.003 · Cited by 3
Edgetic Perturbations Contribute to Phenotypic Variability in PEX26 Deficiency
Lotz-Havla, A. S., Woidy, M., Guder, P., Schmiesing, J., Erdmann, R., Waterham, H. R., Muntau, A. C., & Gersting, S. W. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.726174 · Cited by 4
Metadata
- Authors
- Kemp, S., Wei, H.-M., Lu, J.-F., Braiterman, L. T., McGuinness, M. C., Moser, A. B., Watkins, P. A., & Smith, K. D.
- Affiliations
- Kennedy Krieger Institute (US)
- Corresponding author
- Smith, Kirby D.
- Venue
- Nature Medicine
- Published
- 1998-11
- Volume
- 4
- Issue
- 11
- Pages
- 1261-1268
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- DOI
- 10.1038/3242
- OpenAlex
- W2035026471
- Cited by
- 249
- References
- 57
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 3 · 2022: 4 · 2021: 6 · 2020: 3 · 2019: 3 · 2018: 7 · 2017: 5 · 2016: 5 · 2015: 4 · 2014: 7 · 2013: 12 · 2012: 7
- FWCI
- 13.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Funders
- National Institutes of Health (1r01dk051149-01)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK51149)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD24061, HD-10981, P30HD024061, P01HD010981)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- X-linked adrenoleukodystrophy, gene redundancy, 4-phenylbutyric acid, peroxisomal membrane proteins, ALDP, very long chain fatty acids, fatty acid beta-oxidation, peroxisome proliferation, peroxisomal disorders, dietary therapy
- MeSH terms
- ATP Binding Cassette Transporter, Subfamily D, ATP Binding Cassette Transporter, Subfamily D, Member 1, Adrenoleukodystrophy, Animals, Cell Line, Cells, Cultured, Fibroblasts, Multigene Family, Humans, Lymphocytes, Microbodies, Phenylbutyrates, Proteins, X Chromosome, Genetic Therapy, DNA Primers, Mice, Knockout, ATP-Binding Cassette Transporters, Reverse Transcriptase Polymerase Chain Reaction, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.